SCHEMBL20010583

SCHEMBL20010583

CCOCCC(=O)NC(CC(=O)NC(C)NC(=O)C(C)N1C(=O)C=CC1=O)CC(=O)NC(C)NC(=O)C(C)N1C(=O)C=CC1=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14870356 0.84 MGLL (0.34) NAMPT
SCHEMBL16203709 0.82 KDM4E (0.31) —
SCHEMBL13448309 0.80 POLB (0.35) —
SCHEMBL11955673 0.80 POLB (0.32) —
SCHEMBL12505905 0.79 HTT (0.35) —
SCHEMBL327645 0.79 ACACB (0.31) —
SCHEMBL14870355 0.76 MGLL (0.39) NAMPT
SCHEMBL11955679 0.76 POLB (0.32) —
SCHEMBL12421897 0.74 POLB (0.32) —
SCHEMBL10310591 0.73 ALDH1A1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180085468-A1 CONJUGATES OF AN IL-2 MOIETY AND A POLYMER NEKTAR THERAPEUTICS 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180085468-A1 CONJUGATES OF AN IL-2 MOIETY AND A POLYMER IL2, IL2RA, ILF2 NAMPT 3372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback